Search research articles
Contact Us
Filters
Showing results (231-240 of 560) with videos related to
Page
of 56
Sort By:
American Journal of Obstetrics and Gynecology
|
May 1, 1994
Coordinate expression of urinary-type plasminogen activator and its receptor accompanies malignant transformation of the ovarian surface epithelium
T N Young, G C Rodriguez, T L Moser, et al.
International Journal of Cancer
|
February 15, 1994
Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma
T L Moser, T N Young, G C Rodriguez, et al.
Cancer Research
|
July 26, 2000
Differential signaling by an anti-p185(HER2) antibody and heregulin
X F Le, R Vadlamudi, A McWatters, et al.
Oncogene
|
January 10, 2002
Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C alpha activity
X F Le, M Marcelli, A McWatters, et al.
Blood
|
August 1, 1981
Absence of common ALL antigen on normal bipotent myeloid, erythroid, and granulocyte progenitors
L A Clavell, J M Lipton, R C Bast, et al.
Gynecologic Oncology
|
February 13, 2001
Regulation of invasion of epithelial ovarian cancer by transforming growth factor-beta
G C Rodriguez, C Haisley, J Hurteau, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 1, 1979
Immunotherapy of a murine ovarian carcinoma with Corynebacterium parvum and specific heteroantiserum. I. Activation of peritoneal cells to mediate antibody-dependent cytotoxicity
R C Bast, R C Knapp, A K Mitchell, et al.
American Journal of Obstetrics and Gynecology
|
February 4, 2012
Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age
Richard G Moore, Michael Craig Miller, Elizabeth E Eklund, et al.
American Journal of Obstetrics and Gynecology
|
January 1, 1993
The effect of antibodies and immunotoxins reactive with HER-2/neu on growth of ovarian and breast cancer cell lines
G C Rodríguez, M P Boente, A Berchuck, et al.
Cancer Research
|
March 1, 1983
Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement
R C Bast, J Ritz, J M Lipton, et al.
Page
of 56
Search research articles
Search
Showing results (231-240 of 560) with videos related to
Sort By:
Page
of 56
American Journal of Obstetrics and Gynecology
|
May 1, 1994
Coordinate expression of urinary-type plasminogen activator and its receptor accompanies malignant transformation of the ovarian surface epithelium
T N Young, G C Rodriguez, T L Moser, et al.
International Journal of Cancer
|
February 15, 1994
Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma
T L Moser, T N Young, G C Rodriguez, et al.
Cancer Research
|
July 26, 2000
Differential signaling by an anti-p185(HER2) antibody and heregulin
X F Le, R Vadlamudi, A McWatters, et al.
Oncogene
|
January 10, 2002
Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C alpha activity
X F Le, M Marcelli, A McWatters, et al.
Blood
|
August 1, 1981
Absence of common ALL antigen on normal bipotent myeloid, erythroid, and granulocyte progenitors
L A Clavell, J M Lipton, R C Bast, et al.
Gynecologic Oncology
|
February 13, 2001
Regulation of invasion of epithelial ovarian cancer by transforming growth factor-beta
G C Rodriguez, C Haisley, J Hurteau, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 1, 1979
Immunotherapy of a murine ovarian carcinoma with Corynebacterium parvum and specific heteroantiserum. I. Activation of peritoneal cells to mediate antibody-dependent cytotoxicity
R C Bast, R C Knapp, A K Mitchell, et al.
American Journal of Obstetrics and Gynecology
|
February 4, 2012
Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age
Richard G Moore, Michael Craig Miller, Elizabeth E Eklund, et al.
American Journal of Obstetrics and Gynecology
|
January 1, 1993
The effect of antibodies and immunotoxins reactive with HER-2/neu on growth of ovarian and breast cancer cell lines
G C Rodríguez, M P Boente, A Berchuck, et al.
Cancer Research
|
March 1, 1983
Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement
R C Bast, J Ritz, J M Lipton, et al.
Page
of 56